Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

ETA antagonist has positive effects on pulmonary vascular resistance in patients with HF

Nov. 12, 1998

KGF-2 shows promise for treating IBD

Nov. 12, 1998

Team from Angiotech demonstrates paclitaxel's potential as an antipsoriatic

Nov. 12, 1998

S-18127 characterized as a selective, structurally novel 5-HT1B/1D receptor antagonist

Nov. 12, 1998

Levosimendan clinical results presented this week at AHA meeting

Nov. 12, 1998

Radiopharmaceutical for chronic knee synovitis in development at British university

Nov. 11, 1998

Cytel's VLA4 antagonist shows potential for treating allergic lung inflammation

Nov. 11, 1998

Inhibition of cytokine production contributes to the antiinflammatory activity of orazipone

Nov. 11, 1998

Photoangioplasty with Antrin reduces atherosclerotic plaque in rabbit models

Nov. 11, 1998

Neuroprotective effects of NCC-161, a new neuronal calcium antagonist

Nov. 11, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...